{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:03:09Z","timestamp":1779930189036,"version":"3.53.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Telethon Foundation","doi-asserted-by":"publisher","award":["GMR23T2153"],"award-info":[{"award-number":["GMR23T2153"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["GR-2018-12365358"],"award-info":[{"award-number":["GR-2018-12365358"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell&apos;Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.stemcr.2025.102711","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T19:59:40Z","timestamp":1763063980000},"page":"102711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models"],"prefix":"10.1016","volume":"20","author":[{"given":"Mafalda","family":"Rizzuti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pagliari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"D\u2019Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Ottoboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo Pietro","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0797-8282","authenticated-orcid":false,"given":"Elena","family":"Abati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stemcr.2025.102711_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18293","article-title":"Charcot-Marie-Tooth type 2A in vivo models: Current updates","volume":"28","author":"Abati","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.stemcr.2025.102711_bib2","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1038\/s41598-022-10220-0","article-title":"Clinical and genetic features of a cohort of patients with MFN2-related neuropathy","volume":"12","author":"Abati","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.stemcr.2025.102711_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106467","article-title":"Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives","volume":"193","author":"Alberti","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.stemcr.2025.102711_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2008.01.010","article-title":"Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations","volume":"211","author":"Amiott","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1523\/JNEUROSCI.4798-06.2007","article-title":"Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations","volume":"27","author":"Baloh","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.stemcr.2025.102711_bib6","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamaneurol.2014.629","article-title":"Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features","volume":"71","author":"Bombelli","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib7","doi-asserted-by":"crossref","first-page":"iv-22","DOI":"10.1111\/ane.12013","article-title":"Genetic epidemiology of Charcot-Marie-Tooth disease","volume":"126","author":"Braathen","year":"2012","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.stemcr.2025.102711_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.mcn.2013.07.007","article-title":"A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells","volume":"56","author":"Burkhardt","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.stemcr.2025.102711_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.expneurol.2009.05.003","article-title":"Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A","volume":"218","author":"Cartoni","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14119","article-title":"MFN2 overexpression in skeletal muscles of young and old mice causes a mild hypertrophy without altering mitochondrial respiration and H2O2 emission","volume":"240","author":"Cefis","year":"2024","journal-title":"Acta Physiol."},{"key":"10.1016\/j.stemcr.2025.102711_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stemcr.2025.102711_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nbt.2249","article-title":"Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors","volume":"30","author":"Chambers","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stemcr.2025.102711_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067276","article-title":"Axonal Transport Defects in a Mitofusin 2 Loss of Function Model of Charcot-Marie-Tooth Disease in Zebrafish","volume":"8","author":"Chapman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.stemcr.2025.102711_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1083\/jcb.200211046","article-title":"Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development","volume":"160","author":"Chen","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.stemcr.2025.102711_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12640-024-00721-3","article-title":"How is Excitotoxicity Being Modelled in iPSC-Derived Neurons?","volume":"42","author":"Cheng","year":"2024","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.stemcr.2025.102711_bib16","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/brain\/awl174","article-title":"Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations","volume":"129","author":"Chung","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.stemcr.2025.102711_bib17","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1021\/acs.jmedchem.0c00366","article-title":"Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases","volume":"63","author":"Dang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.stemcr.2025.102711_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.809942","article-title":"HDAC6 Interacts With Poly (GA) and Modulates its Accumulation in c9FTD\/ALS","volume":"9","author":"del Rosso","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.stemcr.2025.102711_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1083\/jcb.200611080","article-title":"Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations","volume":"176","author":"Detmer","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.stemcr.2025.102711_bib20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nrm2275","article-title":"Functions and dysfunctions of mitochondrial dynamics","volume":"8","author":"Detmer","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.stemcr.2025.102711_bib21","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050703","article-title":"Mitofusin gain and loss of function drive pathogenesis in Drosophila models of CMT2A neuropathy","volume":"21","author":"El Fissi","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.stemcr.2025.102711_bib22","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201745241","article-title":"Mitofusin gain and loss of function drive pathogenesis in Drosophila models of CMT2A neuropathy","volume":"19","author":"El Fissi","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.stemcr.2025.102711_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jb\/mvg150","article-title":"Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion","volume":"134","author":"Eura","year":"2003","journal-title":"J. Biochem."},{"key":"10.1016\/j.stemcr.2025.102711_bib24","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106177","article-title":"HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations","volume":"40","author":"Fazal","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.stemcr.2025.102711_bib25","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/WNL.0b013e31821a441e","article-title":"MFN2 mutations cause severe phenotypes in most patients with CMT2A","volume":"76","author":"Feely","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.stemcr.2025.102711_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/jpet.122.001332","article-title":"Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A","volume":"383","author":"Franco","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.stemcr.2025.102711_bib27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61119","article-title":"Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A","volume":"9","author":"Franco","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.stemcr.2025.102711_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature20156","article-title":"Correcting mitochondrial fusion by manipulating mitofusin conformations","volume":"540","author":"Franco","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2025.102711_bib29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp-2014-308826","article-title":"CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis","volume":"86","author":"Fridman","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.stemcr.2025.102711_bib30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41467-017-00911-y","article-title":"HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stemcr.2025.102711_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/brain\/103.2.259","article-title":"The clinical features of hereditary motor and sensory neuropathy types I and II","volume":"103","author":"Harding","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.stemcr.2025.102711_bib32","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1073\/pnas.1318951111","article-title":"Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic \u03b2-cell function in diabetes","volume":"111","author":"Hoshino","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stemcr.2025.102711_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.yjmcc.2011.10.008","article-title":"p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia","volume":"52","author":"Hoshino","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.stemcr.2025.102711_bib34","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1038\/ncomms3308","article-title":"Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart","volume":"4","author":"Hoshino","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stemcr.2025.102711_bib35","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2009.127","article-title":"Differentiation of spinal motor neurons from pluripotent human stem cells","volume":"4","author":"Hu","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stemcr.2025.102711_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejcb.2007.04.002","article-title":"Mitochondrial clustering induced by overexpression of the mitochondrial fusion protein Mfn2 causes mitochondrial dysfunction and cell death","volume":"86","author":"Huang","year":"2007","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.stemcr.2025.102711_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108588","article-title":"Small Molecule SARM1 Inhibitors Recapitulate the SARM1-\/- Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate","volume":"34","author":"Hughes","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.stemcr.2025.102711_bib38","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/s41467-021-22117-z","article-title":"Defective metabolic programming impairs early neuronal morphogenesis in neural cultures and an organoid model of Leigh syndrome","volume":"12","author":"Inak","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stemcr.2025.102711_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/stmcls\/sxab006","article-title":"Exploring Motor Neuron Diseases Using iPSC Platforms","volume":"40","author":"Johns","year":"2022","journal-title":"Stem Cell."},{"key":"10.1016\/j.stemcr.2025.102711_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/jnnp-2018-318834","article-title":"Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development","volume":"90","author":"Juneja","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.stemcr.2025.102711_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1085-9489.2005.10111.x","article-title":"Genetic testing in inherited peripheral neuropathies","volume":"10","author":"Klein","year":"2005","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.stemcr.2025.102711_bib42","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/hmg\/ddz008","article-title":"MFN2 mutations in Charcot-Marie-Tooth disease alter mitochondria-associated ER membrane function but do not impair bioenergetics","volume":"28","author":"Larrea","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.stemcr.2025.102711_bib43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/WCO.0000000000000735","article-title":"Charcot-Marie-Tooth disease and related disorders: an evolving landscape","volume":"32","author":"Laur\u00e1","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cellimm.2008.06.003","article-title":"Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease","volume":"253","author":"Leal","year":"2008","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.stemcr.2025.102711_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.21086","article-title":"Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease","volume":"61","author":"Loiseau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nbt.3049","article-title":"Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes","volume":"33","author":"Maury","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stemcr.2025.102711_bib47","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1523\/JNEUROSCI.6248-09.2010","article-title":"Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro\/Milton complex","volume":"30","author":"Misko","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.stemcr.2025.102711_bib48","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3390\/ijms20143419","article-title":"Charcot-Marie-Tooth: From Molecules to Therapy","volume":"20","author":"Morena","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.stemcr.2025.102711_bib49","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jnnp-2012-302451","article-title":"Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing","volume":"83","author":"Murphy","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.stemcr.2025.102711_bib50","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1212\/01.wnl.0000311275.89032.22","article-title":"Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations","volume":"70","author":"Nicholson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.stemcr.2025.102711_bib51","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/cpt.562","article-title":"Modeling Drug-Induced Neuropathy Using Human iPSCs for Predictive Toxicology","volume":"101","author":"Ohara","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.stemcr.2025.102711_bib52","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S1474-4422(09)70110-3","article-title":"Diagnosis, natural history, and management of Charcot-Marie-Tooth disease","volume":"8","author":"Pareyson","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib53","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/WCO.0000000000000474","article-title":"New developments in Charcot-Marie-Tooth neuropathy and related diseases","volume":"30","author":"Pareyson","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib54","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1038\/s41598-020-66266-5","article-title":"Energy metabolism and mitochondrial defects in X-linked Charcot-Marie-Tooth (CMTX6) iPSC-derived motor neurons with the p.R158H PDK3 mutation","volume":"10","author":"Perez-Siles","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.stemcr.2025.102711_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34587","article-title":"HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS","volume":"10","author":"Phipps","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.stemcr.2025.102711_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113281","article-title":"HDAC6 inhibition promotes \u03b1-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice","volume":"328","author":"Picci","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib57","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41582-019-0254-5","article-title":"Next-generation sequencing in Charcot-Marie-Tooth disease: opportunities and challenges","volume":"15","author":"Pipis","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib58","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/ene.15860","article-title":"Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: Data from the National CMT Registry","volume":"30","author":"Pisciotta","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib59","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/B978-0-323-98818-6.00009-1","article-title":"Hereditary neuropathy","volume":"195","author":"Pisciotta","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib60","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jns.12145","article-title":"Mutational mechanisms in MFN2-related neuropathy: compound heterozygosity for recessive and semidominant mutations","volume":"20","author":"Piscosquito","year":"2015","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.stemcr.2025.102711_bib61","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1212\/WNL.0b013e3182242d4d","article-title":"Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations","volume":"77","author":"Polke","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.stemcr.2025.102711_bib62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13064-016-0058-x","article-title":"Charcot-Marie-Tooth 2b associated Rab7 mutations cause axon growth and guidance defects during vertebrate sensory neuron development","volume":"11","author":"Ponomareva","year":"2016","journal-title":"Neural Dev."},{"key":"10.1016\/j.stemcr.2025.102711_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1529-8027.2011.00324.x","article-title":"Charcot-Marie-Tooth disease","volume":"16","author":"Reilly","year":"2011","journal-title":"J. Peripher. Nerv. Syst. JPNS"},{"key":"10.1016\/j.stemcr.2025.102711_bib64","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00018-023-05018-w","article-title":"Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A","volume":"80","author":"Rizzo","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.stemcr.2025.102711_bib65","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1093\/hmg\/ddw258","article-title":"Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons","volume":"25","author":"Rizzo","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.stemcr.2025.102711_bib66","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1007\/s12035-024-03998-9","article-title":"Shaping the Neurovascular Unit Exploiting Human Brain Organoids","volume":"61","author":"Rizzuti","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.stemcr.2025.102711_bib67","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.aao1785","article-title":"MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A","volume":"360","author":"Rocha","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.stemcr.2025.102711_bib68","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrneurol.2013.179","article-title":"Clinical implications of genetic advances in Charcot-Marie-Tooth disease","volume":"9","author":"Rossor","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/brain\/awr323","article-title":"The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy \u201cplus\u201d phenotype","volume":"135","author":"Rouzier","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.stemcr.2025.102711_bib70","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.22166","article-title":"Charcot-Marie-Tooth disease subtypes and genetic testing strategies","volume":"69","author":"Saporta","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib71","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.expneurol.2014.10.005","article-title":"Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties","volume":"263","author":"Saporta","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161566","article-title":"A SARM1-mitochondrial feedback loop drives neuropathogenesis in a Charcot-Marie-Tooth disease type 2A rat model","volume":"132","author":"Sato-Yamada","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.stemcr.2025.102711_bib73","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1021\/acs.jmedchem.0c02210","article-title":"Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model","volume":"64","author":"Shen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.stemcr.2025.102711_bib74","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jns.12564","article-title":"Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro","volume":"28","author":"Stavropoulos","year":"2023","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.stemcr.2025.102711_bib75","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.stemcr.2021.03.029","article-title":"Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition","volume":"16","author":"Stoklund Dittlau","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stemcr.2025.102711_bib76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2015.05.033","article-title":"MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives","volume":"356","author":"Stuppia","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.stemcr.2025.102711_bib77","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jns.12155","article-title":"Semi-dominant mutations in MFN2-related neuropathy and implications for genetic counselling","volume":"21","author":"Tomaselli","year":"2016","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.stemcr.2025.102711_bib78","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/acn3.70067","article-title":"Histone Deacetylase 6 Brain PET in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder","volume":"12","author":"Vanderlinden","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib79","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s12276-024-01250-x","article-title":"Advances and challenges in modeling inherited peripheral neuropathies using iPSCs","volume":"56","author":"Van Lent","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.stemcr.2025.102711_bib80","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/brain\/awac475","article-title":"Downregulation of PMP22 ameliorates myelin defects in iPSC-derived human organoid cultures of CMT1A","volume":"146","author":"Van Lent","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.stemcr.2025.102711_bib81","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/brain\/awab226","article-title":"Induced pluripotent stem cell-derived motor neurons of CMT type 2 patients reveal progressive mitochondrial dysfunction","volume":"144","author":"Van Lent","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.stemcr.2025.102711_bib82","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/brain\/awl126","article-title":"MFN2 mutation distribution and genotype\/phenotype correlation in Charcot-Marie-Tooth type 2","volume":"129","author":"Verhoeven","year":"2006","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.stemcr.2025.102711_bib83","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00401-012-1036-y","article-title":"Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion","volume":"125","author":"Vielhaber","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.stemcr.2025.102711_bib84","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.stemcr.2025.102711_bib85","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202402921","article-title":"The MFN2 Q367H variant reveals a novel pathomechanism connected to mtDNA-mediated inflammation","volume":"8","author":"Zaman","year":"2025","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.stemcr.2025.102711_bib86","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1172\/JCI124194","article-title":"Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model","volume":"129","author":"Zhou","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.stemcr.2025.102711_bib87","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ng1341","article-title":"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A","volume":"36","author":"Z\u00fcchner","year":"2004","journal-title":"Nat. Genet."}],"container-title":["Stem Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671125003157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671125003157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:22:17Z","timestamp":1778858537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213671125003157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":87,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2213671125003157"],"URL":"https:\/\/doi.org\/10.1016\/j.stemcr.2025.102711","relation":{},"ISSN":["2213-6711"],"issn-type":[{"value":"2213-6711","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stemcr.2025.102711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Stem Cell Research.","name":"copyright","label":"Copyright"}],"article-number":"102711"}}